Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are too narrow, the meta-analysis answers a overly specific question.
Heterogeneity as information rather than as a nuisance posts 91–96
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
This follows post #89 rather than contradicting it.
Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High heterogeneity means effects genuinely differ across studies. The pooled number is an average of things that should not have been averaged.
Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest plot with only large studies on the positive end is a red flag for unpublished small negative studies.
Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A narrow confidence interval around a meaningless centre is less useful than a wider interval that shows real differences.
Coming back to post #93, because the follow-up matters more than the original answer.
When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents nothing in particular. Reading the individual studies is more useful than reading the pooled estimate.
Picking up post #93: that is the part I would want checked first.
Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High heterogeneity means effects genuinely differ across studies. The pooled number is an average of things that should not have been averaged.
This topic was referenced in
- Coming back to: Reading a meta-analysis you disagree with, fairlyEvidence › Meta-analyses · 34 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
About the Meta-analyses category
Pooled estimates, heterogeneity, publication bias, and when pooling was a mistake. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 15k | 13mo | |
|
Revisiting: What pooling buys you and what it destroys
On the subject in the title: Revisiting: What pooling buys you and what it destroys Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before posting; the…
|
+97 | 107 | 4k | 19h |
|
Coming back to: Reading a meta-analysis you disagree with, fairly
Reading a meta-analysis you disagree with, fairly Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP 1 ( N Engl J Med , 2021) cited in support of a claim I do…
|
+30 | 34 | 9.3k | 17mo |
|
Pooling trials with different estimands — what changed since
Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURPASS-4 ( Lancet , 2021) and finding…
|
+57 | 64 | 12k | 7mo |
|
Individual participant data versus aggregate data
Posting this under the heading it deserves: Individual participant data versus aggregate data Everything below is what sits behind that. Session topic: SCALE ( N Engl J Med , 2015). Please read it before…
|
+30 | 34 | 64k | 14mo |
Related topics — sharing the tags heterogeneity, risk of bias, meta-analysis
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Is there a ceiling dose beyond which semaglutide stops adding benefit?
Is there a ceiling dose beyond which semaglutide stops adding benefit? I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in…
|
2 | 14k | 2mo | |
|
About the Statistics category
Effect sizes, intervals, multiplicity, and the difference between absent and undetected. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+4 | 8 | 2.3k | 7mo |
|
Sample size intuition for a personal experiment
On the subject in the title: Sample size intuition for a personal experiment Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting; the discussion is…
|
4 | 62k | 18mo | |
|
The "under review" status pill and when a moderator applies it
Posting this under the heading it deserves: The "under review" status pill and when a moderator applies it Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it…
|
+96 | 119 | 17k | 3mo |
|
Measurement error in home scales, with a worked standard deviation — a second dataset
Measurement error in home scales, with a worked standard deviation — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with SURPASS-2…
|
2 | 13k | 7mo |